EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci – INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Hidalgo-Tenorio, C; Sadyrbaeva-Dolgova, S; Enríquez-Gómez, A; Muñoz, P; Plata-Ciezar, A; Miró, JM; Alarcón, A; Martínez-Marcos, FJ; Loeches, B; Escrihuela-Vidal, F; Vinuesa, D; Herrero, C; Boix-Palop, L; Arenas, MD; Vázquez, EG; de las Revillas, FA – 2023...